Skip to main content
Erschienen in: Cancer Causes & Control 2/2007

01.03.2007 | Brief Report

Lung cancer mortality and body mass index in a Japanese cohort: findings from the Japan Collaborative Cohort Study (JACC Study)

verfasst von: Takaaki Kondo, Yoko Hori, Hiroshi Yatsuya, Koji Tamakoshi, Hideaki Toyoshima, Yoshikazu Nishino, Nao Seki, Yoshinori Ito, Koji Suzuki, Kotaro Ozasa, Yoshiyuki Watanabe, Masahiko Ando, Kenji Wakai, Akiko Tamakoshi

Erschienen in: Cancer Causes & Control | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

Objective:

To determine the relationship of body mass index (BMI) and BMI changes during adulthood to lung cancer mortality in a large-sized Japanese cohort.

Methods:

We followed 29,350 men for a maximum of 11 years in the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study), which was initiated from 1988 to 1990. Complementary log–log modeling was employed with age, smoking status, and family history of lung cancer as covariates. Anthropometric measurements used were BMI at baseline, BMI around age 20, and adulthood BMI loss defined between the two measurements. Independent effects of these three measurements on lung cancer mortality were evaluated by applying the method of generalized estimation equations to the model for adjustment of intra-individual correlation.

Results:

Never smokers showed that high BMI both at baseline and around age 20 significantly predict lung cancer mortality (P < 0.05). Adulthood BMI loss significantly (P < 0.05) elevated the risk for lung cancer mortality among current smokers, implying their enhanced vulnerability to lung cancer risk among smokers.

Conclusions:

The risk for lung cancer mortality is elevated by a mechanism related to smoking-induced weight loss during adulthood.
Literatur
1.
Zurück zum Zitat Hoffmanns MDAF, Kromhout D, De Lezenne Coulander C (1998) Body mass index at the age 18 and its effects on 32-year-mortality from coronary heart disease and cancer. J Clin Epidemiol 42:513–520CrossRef Hoffmanns MDAF, Kromhout D, De Lezenne Coulander C (1998) Body mass index at the age 18 and its effects on 32-year-mortality from coronary heart disease and cancer. J Clin Epidemiol 42:513–520CrossRef
2.
Zurück zum Zitat Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath Jr CW (1999) Body-mass index and mortality in a prospective cohort of US adults N Engl J Med 341:1097–1105PubMedCrossRef Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath Jr CW (1999) Body-mass index and mortality in a prospective cohort of US adults N Engl J Med 341:1097–1105PubMedCrossRef
3.
Zurück zum Zitat Nomura A, Heibrun LK, Stemmermann GN (1985) Body mass index as a predictor of cancer in men. J Natl Cancer Inst 74:319–323PubMed Nomura A, Heibrun LK, Stemmermann GN (1985) Body mass index as a predictor of cancer in men. J Natl Cancer Inst 74:319–323PubMed
4.
Zurück zum Zitat Seidell JC, Veschuren WM, van Leer EM, Kromhout D (1996) Overweight, underweight, and mortality—a prospective study of 48,287 men and women. Arch Intern Med 156:958–963PubMedCrossRef Seidell JC, Veschuren WM, van Leer EM, Kromhout D (1996) Overweight, underweight, and mortality—a prospective study of 48,287 men and women. Arch Intern Med 156:958–963PubMedCrossRef
5.
Zurück zum Zitat Kark JD, Yaari SY, Rasooly I, Goldbourt U (1995) Are lean smokers at increased risk of lung cancer? The Islaeli Civil Servant Cancer Study. Arch Intern Med 155:2409–2416PubMedCrossRef Kark JD, Yaari SY, Rasooly I, Goldbourt U (1995) Are lean smokers at increased risk of lung cancer? The Islaeli Civil Servant Cancer Study. Arch Intern Med 155:2409–2416PubMedCrossRef
6.
Zurück zum Zitat Goodman MT, Wilkens LR (1993) Relation of body size and the risk of lung cancer. Nutr Cancer 20:179–186PubMedCrossRef Goodman MT, Wilkens LR (1993) Relation of body size and the risk of lung cancer. Nutr Cancer 20:179–186PubMedCrossRef
7.
Zurück zum Zitat Rauscher GH, Mayne ST, Janerich DT (2000) Relation between body mass index and lung cancer risk in men and women never and former smokers. Am J Epidemiol 152:506–513PubMedCrossRef Rauscher GH, Mayne ST, Janerich DT (2000) Relation between body mass index and lung cancer risk in men and women never and former smokers. Am J Epidemiol 152:506–513PubMedCrossRef
8.
Zurück zum Zitat Hinds MW, Stemmermann GN, Yang HY, Kolonel LN, Lee J, Wegner E (1981) Differences in lung cancer risk from smoking among Japanese, Chinese and Hawaiian women in Hawaii. Int J Cancer 27:297–302PubMed Hinds MW, Stemmermann GN, Yang HY, Kolonel LN, Lee J, Wegner E (1981) Differences in lung cancer risk from smoking among Japanese, Chinese and Hawaiian women in Hawaii. Int J Cancer 27:297–302PubMed
9.
Zurück zum Zitat Ohno Y, Tamakoshi A, The JACC Study Group (2001) Japan Collaborative Cohort Study for evaluation of cancer risk sponsored by Monbusho (JACC Study). J Epidemiol 11:144–150PubMed Ohno Y, Tamakoshi A, The JACC Study Group (2001) Japan Collaborative Cohort Study for evaluation of cancer risk sponsored by Monbusho (JACC Study). J Epidemiol 11:144–150PubMed
10.
Zurück zum Zitat Allison PD (2001) Survival analysis using the SAS system: a practical guide SAS Institute Inc., Cary, NC Allison PD (2001) Survival analysis using the SAS system: a practical guide SAS Institute Inc., Cary, NC
11.
Zurück zum Zitat Allison PD (1999) Logistic regression using the SAS system: theory and application SAS Institute Inc, Cary, NC Allison PD (1999) Logistic regression using the SAS system: theory and application SAS Institute Inc, Cary, NC
12.
Zurück zum Zitat Hanley JA, Negassa A, Edwardes MD, Forrester JE (2003) Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol 157:364–375PubMedCrossRef Hanley JA, Negassa A, Edwardes MD, Forrester JE (2003) Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol 157:364–375PubMedCrossRef
13.
Zurück zum Zitat Gamayunova VB, Bobrov YF, Tsyrlina EV, Evtushenko TP, Berstein LM (1997) Comparative study of blood insulin levels in breast and endometrial cancer patients. Neoplasma 44:123–126PubMed Gamayunova VB, Bobrov YF, Tsyrlina EV, Evtushenko TP, Berstein LM (1997) Comparative study of blood insulin levels in breast and endometrial cancer patients. Neoplasma 44:123–126PubMed
14.
Zurück zum Zitat Tripkovic I, Tripkovic A, Ivanisevic Z, Capkun V, Zekan L (2004) Insulin increase in colon cancerogenesis: a case–control study. Arch Med Res 35:215–219PubMedCrossRef Tripkovic I, Tripkovic A, Ivanisevic Z, Capkun V, Zekan L (2004) Insulin increase in colon cancerogenesis: a case–control study. Arch Med Res 35:215–219PubMedCrossRef
16.
Zurück zum Zitat Shimokata H, Tobin JD, Muller DC, Elahi D, Coon PJ, Andres R (1989) Studies in the distribution of body fat: I. Effects of age, sex, and obesity. J Gerontol 44:66–73 Shimokata H, Tobin JD, Muller DC, Elahi D, Coon PJ, Andres R (1989) Studies in the distribution of body fat: I. Effects of age, sex, and obesity. J Gerontol 44:66–73
17.
Zurück zum Zitat Ross R, Rissanen J, Hudson R (1996) Sensitivity associated with the identification of visceral adipose tissue levels using waist circumference in men and women: effects of weight loss. Int J Obes Relat Metab Disord 20:533–538PubMed Ross R, Rissanen J, Hudson R (1996) Sensitivity associated with the identification of visceral adipose tissue levels using waist circumference in men and women: effects of weight loss. Int J Obes Relat Metab Disord 20:533–538PubMed
18.
Zurück zum Zitat Rosengren A, Wedel H, Wilhelmsen L (1999) Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J 20:269–277PubMedCrossRef Rosengren A, Wedel H, Wilhelmsen L (1999) Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J 20:269–277PubMedCrossRef
19.
Zurück zum Zitat Stevens J, Keil JE, Waid LR, Gazes PC (1990) Accuracy of current, 4-year, and 28-year self-reported body weight in an elderly population. Am J Epidemiol 132:1156–1163PubMed Stevens J, Keil JE, Waid LR, Gazes PC (1990) Accuracy of current, 4-year, and 28-year self-reported body weight in an elderly population. Am J Epidemiol 132:1156–1163PubMed
20.
Zurück zum Zitat Tamakoshi K, Yatsuya H, Kondo T, et al (2003) The accuracy of long-term recall of past body weight in Japanese adult men. Int J Obesity 27:247–252CrossRef Tamakoshi K, Yatsuya H, Kondo T, et al (2003) The accuracy of long-term recall of past body weight in Japanese adult men. Int J Obesity 27:247–252CrossRef
Metadaten
Titel
Lung cancer mortality and body mass index in a Japanese cohort: findings from the Japan Collaborative Cohort Study (JACC Study)
verfasst von
Takaaki Kondo
Yoko Hori
Hiroshi Yatsuya
Koji Tamakoshi
Hideaki Toyoshima
Yoshikazu Nishino
Nao Seki
Yoshinori Ito
Koji Suzuki
Kotaro Ozasa
Yoshiyuki Watanabe
Masahiko Ando
Kenji Wakai
Akiko Tamakoshi
Publikationsdatum
01.03.2007
Verlag
Kluwer Academic Publishers
Erschienen in
Cancer Causes & Control / Ausgabe 2/2007
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-006-0069-8

Weitere Artikel der Ausgabe 2/2007

Cancer Causes & Control 2/2007 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.